The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Abstract
To improve the efficiency of orally delivered vaccines, PEGylated PLGA-based nanoparticles displaying RGD molecules at their surface were designed to target human M cells. RGD grafting was performed by an original method called "photografting" which covalently linked RGD peptides mainly on the PEG moiety of the PCL-PEG, included in the formulation. First, three non-targeted formulations with size and zeta potential adapted to M cell uptake and stable in gastro-intestinal fluids, were developed. Their transport by an in vitro model of the human Follicle associated epithelium (co-cultures) was largely increased as compared to mono-cultures (Caco-2 cells). RGD-labelling of nanoparticles significantly increased their transport by co-cultures, due to interactions between the RGD ligand and the beta(1) intregrins detected at the apical surface of co-cultures. In vivo studies demonstrated that RGD-labelled nanoparticles particularly concentrated in M cells. Finally, ovalbumin-loaded nanoparticles were orally administrated to mice and induced an IgG response, attesting antigen ability to elicit an immune response after oral delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, very low IL-4 and significantly higher IFN-γ production of spleen cells was observed in animals immunized with particles compared with mice being fed unprotected OVA, which was even more pronounced when the β1 integrin on M cells was specifically targeted by an RGD-containing peptide [76].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [76]
In the citing paper
“Recently, it was observed that the encapsulation of antigens into PLGA particles did not only protect from GI digestion, but also initiated specific immune responses by the means of IgG and IFN-γ production at very low antigen amounts [76].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [76]
Citations
Cites
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Self-citationGastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V. D., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 942
Artursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 848
Eldridge, J. H., Hammond, C., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Reductive alkylation of amino groups in proteins
Means, G. E., & Feeney, R. E. (1968) · Biochemistry · doi:10.1021/bi00846a023 · Cited by 680
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
Dressman, J., & Reppas, C. I. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00181-0 · Cited by 586
Epithelial M Cells: Differentiation and Function
Kraehenbühl, J.-P., & Neutra, M. R. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.301 · Cited by 475
Dong, Y., & Feng, S. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.055 · Cited by 472
Research works printed but not linked: 1
- Pourcelle, 2007, PCL–PEG-based nanoparticles grafted with GRGDS peptide: surface analysis, J. Colloid. Interface Sci.
Cited by
Sorted by citations
Items 101–200 of 331
Shreya, A. B., Raut, S. Y., Managuli, R. S., Udupa, N., & Mutalik, S. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1262-2 · Cited by 79
Peptide- and Aptamer-Functionalized Nanovectors for Targeted Delivery of Therapeutics
Pangburn, T. O., Petersen, M. A., Waybrant, B., Adil, M. M., & Kokkoli, E. (2009) · Journal of Biomechanical Engineering · doi:10.1115/1.3160763 · Cited by 80
Ligand-mediated active targeting for enhanced oral absorption
Zhang, X., & Wu, W. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.001 · Cited by 78
Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages
Brandhonneur, N., Chevanne, F., Vié, V., Frisch, B., Primault, R., Le Potier, M.-F., & Le Corre, P. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.013 · Cited by 75
Advanced oral vaccine delivery strategies for improving the immunity
Zhang, Y., Li, M., Du, G., Chen, X., & Sun, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113928 · Cited by 74
Li, Y., Dong, M., Fan-min, K., & Zhou, J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.028 · Cited by 77
Luo, C., Sun, J., Du, Y., & He, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.030 · Cited by 75
das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 74
Folate-mediated chondroitin sulfate-Pluronic® 127 nanogels as a drug carrier
Huang, S., Sun, S.-L., Feng, T.-H., Sung, K.-H., Lui, W.-L., & Wang, L. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.002 · Cited by 72
Zhan, X., Tran, K. K., & Shen, H. Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300190g · Cited by 72
Saneja, A., Kumar, R., Singh, A., Dubey, R. D., Mintoo, M. J., Singh, G., Mondhe, D. M., Panda, A. K., & Gupta, P. N. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.076 · Cited by 71
Coffey, J. W., Gaiha, G. D., & Traverso, G. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030320-092348 · Cited by 72
Joshi, G., Kumar, A., & Sawant, K. K. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1199605 · Cited by 67
Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?
Diab, R., Jaafar‐Maalej, C., Fessi, H., & Maincent, P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9377-y · Cited by 68
Durán‐Lobato, M., Martín‐Banderas, L., Gonçalves, L., Arévalo, M. F., & Almeida, A. J. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2875-y · Cited by 67
Annamalai, T., Pina-Mimbela, R., Kumar, A., Binjawadagi, B., Liu, Z., Renukaradhya, G. J., & Rajashekara, G. (2013) · Poultry Science · doi:10.3382/ps.2012-03004 · Cited by 65
Bucarey, S. A., Noriega, J., Reyes, P., Tapia, C. V., Sáenz, L., Zúñiga, A., & Tobar, J. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.061 · Cited by 65
M cell targeting engineered biomaterials for effective vaccination
Islam, M. A., Firdous, J., Badruddoza, A. Z. M., Reesor, E., Azad, M. A., Hasan, A., Lim, M., Cao, W., Guillemette, S. R., & Cho, C. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.041 · Cited by 64
An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines
Salvador, A., Igartúa, M., Hernández, R. M., & Pedraz, J. L. (2011) · Journal of Drug Delivery · doi:10.1155/2011/181646 · Cited by 63
Targeting of Tumor Endothelium by RGD-Grafted PLGA-Nanoparticles
Danhier, F., Pourcelle, V., Marchand‐Brynaert, J., Jérôme, C., Féron, O., & Véronique Préat, A. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00008-2 · Cited by 62
Self-citationM cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Lo, D. D., Ling, J., & Eckelhoefer, A. H. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-7 · Cited by 62
Harde, H., Agrawal, A. K., & Jain, S. (2014) · Nanomedicine · doi:10.2217/nnm.13.225 · Cited by 61
Beidokhti, H. R. N., Ghaffarzadegan, R., Mirzakhanlouei, S., Ghazizadeh, L., & Dorkoosh, F. A. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-015-0445-3 · Cited by 59
Chen, Y.-L., Wu, J., Wang, J., Zhang, W., Xu, B., Xu, X., & Zong, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4593-3 · Cited by 59
Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles
Fay, F., Quinn, D. J., Gilmore, B., McCarron, P. A., & Scott, C. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.143 · Cited by 58
PCL−PEG-Based Nanoparticles Grafted with GRGDS Peptide: Preparation and Surface Analysis by XPS
Pourcelle, V., Devouge, S., Garinot, M., Véronique Préat, A., & Marchand‐Brynaert, J. (2007) · Biomacromolecules · doi:10.1021/bm700841y · Cited by 56
Self-citationBreaking the barricade of oral chemotherapy through polysaccharide nanocarrier
Dey, M., Das, M., Chowhan, A., & Giri, T. K. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.094 · Cited by 56
Mansoor, F., Earley, B., Cassidy, J. P., Markey, B. K., Doherty, S., & Welsh, M. D. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0481-y · Cited by 54
M cell-targeted delivery of vaccines and therapeutics
KuoLee, R., & Chen, W. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.693 · Cited by 57
Almeida, A., Silva, D., Gonçalves, V. M. F., & Sarmento, B. F. C. C. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0357-8 · Cited by 55
Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma
Ganipineni, L. P., Učakar, B., Joudiou, N., Riva, R., Jérôme, C., Gallez, B., Danhier, F., & Véronique Préat, A. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1567738 · Cited by 54
Self-citationIn vitro identification of targeting ligands of human M cells by phage display
Fiévez, V., Plapied, L., Plaideau, C., Legendre, D., Rieux, A. D., Pourcelle, V., Freichels, H., Jérôme, C., Marchand, J., Véronique Préat, A., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.023 · Cited by 53
Self-citationMishra, N., Goyal, A. K., Tiwari, S., Paliwal, R., Paliwal, S. R., Vaidya, B., Mangal, S., Gupta, M., Dube, D., Mehta, A., et al. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003730425 · Cited by 52
A novel ligand conjugated nanoparticles for oral insulin delivery
Liu, C., Shan, W., Liu, M., Zhu, X. D., Xu, J., Xu, Y., & Huang, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1058433 · Cited by 49
Liu, Y., Wang, F., Shah, Z., Cheng, X., Kong, M., Feng, C., & Chen, X. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.035 · Cited by 48
Braz, L., Grenha, A., Ferreira, D., da Costa, A. M. R., Gamazo, C., & Sarmento, B. F. C. C. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.076 · Cited by 48
Kim, H., Griffith, T. S., & Panyam, J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254953 · Cited by 49
Nanoparticles for mucosal vaccine delivery
Thakur, A., & Foged, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102985-5.00025-5 · Cited by 48
Danhier, F., Učakar, B., Magotteaux, N., Brewster, M. E., & Véronique Préat, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.018 · Cited by 47
Nazarian, S., Gargari, S. L. M., Rasooli, I., Hasannia, S., & Pirooznia, N. (2013) · Microbiological Research · doi:10.1016/j.micres.2013.06.005 · Cited by 46
Bhatt, P., Khatri, N., Kumar, M., Baradia, D., & Misra, A. R. (2014) · Drug Delivery · doi:10.3109/10717544.2014.898348 · Cited by 49
Nanovaccines for oral delivery-formulation strategies and challenges
Karandikar, S., Mirani, A. G., Waybhase, V., Patravale, V. B., & Patankar, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47720-8.00011-0 · Cited by 45
Targeted Strategies for Mucosal Vaccination
Longet, S., Lundahl, M. L. E., & Lavelle, E. C. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00738 · Cited by 47
Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action - Review
da Silva, P. B., Machado, R. T. A., Pironi, A. M., Alves, R. C., de Araújo, P. R., Dragalzew, A. C., Dalberto, I., & Chorilli, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180214102918 · Cited by 45
Current and New Approaches for Mucosal Vaccine Delivery
Rhee, J. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00019-5 · Cited by 46
Pourcelle, V., Freichels, H., Stoffelbach, F., Auzély‐Velty, R., Jérôme, C., & Marchand‐Brynaert, J. (2009) · Biomacromolecules · doi:10.1021/bm900027r · Cited by 45
Self-citationExploiting or overcoming the dome trap for enhanced oral immunization and drug delivery
Qi, J., Zhuang, J., Lv, Y., Lü, Y., & Wu, W. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.021 · Cited by 43
Nanoparticles and microparticles of polymers and polysaccharides to administer fish vaccines
Rivas‐Aravena, A., Sandino, A. M., & Spencer, E. (2013) · Biological Research · doi:10.4067/s0716-97602013000400012 · Cited by 42
A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery
Liau, J. J., Hook, S. M., Prestidge, C. A., & Barnes, T. J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.018 · Cited by 42
Lee, D.-Y., Nurunnabi, M., Kang, S. H., Nafiujjaman, M., Huh, K. M., Lee, Y.-K., & Kim, Y. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01855 · Cited by 42
Takeuchi, I., Taniguchi, Y., Tamura, Y., Ochiai, K., & Makino, K. (2017) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2017.10.047 · Cited by 41
Managuli, R. S., Wang, J. T.-W., Faruqu, F. N., Pandey, A., Jain, S., Al‐Jamal, K. T., & Mutalik, S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110620 · Cited by 41
Use of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40
Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Martín‐Banderas, L., Durán‐Lobato, M., Muñoz-Rubio, I., Alvarez-Fuentes, J., Arévalo, M. F., & Holgado, M. A. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955713804484721 · Cited by 40
Silva, J. M., Vandermeulen, G., Oliveira, V. G., Pinto, S. N., Rodrigues, C. A. B., Salgado, A., Afonso, C. A. M., Viana, A. S., Jérôme, C., Silva, L. C., et al. (2014) · Nanomedicine · doi:10.2217/nnm.14.135 · Cited by 40
Self-citationPreparation and in vitro release of buccal tablets of naringenin-loaded MPEG-PCL nanoparticles
Wang, K., Liu, T., Lin, R., Liu, B., Yang, G., Bu, X., Wang, W., Zhang, P., Zhou, L., & Zhang, J. (2014) · RSC Advances · doi:10.1039/c4ra04920a · Cited by 40
Yang, X., Chen, X., Lei, T., Qin, L., Zhou, Y., Hu, C., Liu, Q., & Gao, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.011 · Cited by 40
From allergen to oral vaccine carrier: A new face of ragweed pollen
Uddin, M. J., & Gill, H. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.003 · Cited by 38
Oral Administration as a Potential Alternative for the Delivery of Small Extracellular Vesicles
Meneses, D. D., Figueroa‐Valdés, A. I., Khoury, M., & Alcayaga‐Miranda, F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030716 · Cited by 36
Film-nanoparticle composite for enhanced oral delivery of alpha-casozepine
Castro, P. M., Baptista, P., Zuccheri, G., Madureira, A. R., Sarmento, B. F. C. C., & Pintado, M. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.05.029 · Cited by 37
A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems
Naskar, S., Das, S. K., Sharma, S., & Kuotsu, K. (2020) · Pharmaceutical Nanotechnology · doi:10.2174/2211738508666201214103010 · Cited by 37
Oral Peptide Delivery: Prioritizing the Leading Technologies
Brayden, D. J., & Mrsny, R. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.114 · Cited by 37
Namasivayam, S. K. R., Nishanth, A., Bharani, R. S. A., Nivedh, K., Syed, N. H., & Rosario Samuel, R. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.175 · Cited by 36
Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review
Oryani, M. A., Nosrati, S., Javid, H., Mehri, A., Hashemzadeh, A., & Karimi‐Shahri, M. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02707-y · Cited by 34
Technological Approaches for Improving Vaccination Compliance and Coverage
Lemoine, C., Thakur, A., Krajišnik, D. R., Guyon, R., Longet, S., Razim, A., Górska, S., Pantelić, I., Milić, J., Nikolić, I., et al. (2020) · Vaccines · doi:10.3390/vaccines8020304 · Cited by 34
Varshosaz, J., Hassanzadeh, F., Sadeghi‐Aliabadi, H., Larian, Z., & Rostami, M. R. (2013) · Chemical Engineering Journal · doi:10.1016/j.cej.2013.11.086 · Cited by 34
Recent Advances in Microparticle and Nanoparticle Delivery Vehicles for Mucosal Vaccination
McNeela, E. A., & Lavelle, E. C. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_140 · Cited by 32
Chen, A., Ni, H.-C., Wang, L., & Chen, J. (2008) · Biomacromolecules · doi:10.1021/bm800485x · Cited by 32
Li, Y., Ma, J., Zhu, H., Gao, X., Dong, H., & Shi, D. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am401573b · Cited by 32
Poly(lactic- co -glycolic acid): The most ardent and flexible candidate in biomedicine!
Roointan, A., Kianpour, S., Memari, F., Gandomani, M., Hayat, S. M. G., & Mohammadi‐Samani, S. (2018) · International Journal of Polymeric Materials · doi:10.1080/00914037.2017.1405350 · Cited by 33
Freichels, H., Danhier, F., Véronique Préat, A., Lecomte, P., & Jérôme, C. (2011) · The International Journal of Artificial Organs · doi:10.5301/ijao.2011.6420 · Cited by 30
Self-citationAdapted nano-carriers for gastrointestinal defense components: surface strategies and challenges
Wang, W., Yan, X., Li, Q., Chen, Z., Wang, Z., & Hu, H. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102277 · Cited by 30
Delivery of plant-made vaccines and therapeutics
Pelosi, A., Shepherd, R., & Walmsley, A. M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.018 · Cited by 30
Drug Carriers for Oral Delivery of Peptides and Proteins: Accomplishments and Future Perspectives
Reis, C. P., Silva, C. O., Martinho, N., & Rosado, C. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.143 · Cited by 31
Optimization of PLGA formulation containing protein or peptide‐based antigen: Recent advances
Hajavi, J., Ebrahimian, M., Sankian, M., Khakzad, M. R., & Hashemi, M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36423 · Cited by 30
Nanovaccines : nanocarriers for antigen delivery
González-Aramúndiz, J. V., Cordeiro, A. S., Csaba, N., de la Fuente, M., & Alonso, M. J. (2012) · Biologie Aujourd hui · doi:10.1051/jbio/2012027 · Cited by 28
Demirbolat, G. M., Altıntaş, L., Yılmaz, Ş., & Değim, İ. T. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.01.006 · Cited by 28
Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination
McCright, J., & Maisel, K. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1695476 · Cited by 27
Aptamer-modified M cell targeting liposomes for oral delivery of macromolecules
He, Y., Huang, Y., Xu, H., Yang, X., Liu, N., Xu, Y., Ma, R., Zhai, J., Ma, Y., & Guan, S. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113109 · Cited by 27
Padhye, T., Maravajjala, K. S., Swetha, K. L., Sharma, S., & Roy, A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102178 · Cited by 28
Erdağı, S. İ., & Yıldız, U. (2019) · New Journal of Chemistry · doi:10.1039/c9nj00659a · Cited by 26
Wang, L., Lin, L., Liu, Yeh, Y., & Cheng, T. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33602 · Cited by 25
Namdee, K., Khongkow, M., Boonrungsiman, S., Nittayasut, N., Asavarut, P., Temisak, S., Saengkrit, N., Puttipipatkhachorn, S., Hajitou, A., Ruxrungtham, K., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.012 · Cited by 24
Shabestarian, H., Tabrizi, M. H., Movahedi, M., Neamati, A., & Sharifnia, F. (2021) · Journal of Microencapsulation · doi:10.1080/02652048.2021.1917715 · Cited by 23
Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy
Masjedi, M., Montahaei, T., Sharafi, Z., & Jalali, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103184 · Cited by 23
Therapeutic Potential of Natural Product-Based Oral Nanomedicines for Stroke Prevention
Mutoh, T., Mutoh, T., Taki, Y., & Ishikawa, T. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3644 · Cited by 25
Ji, Y. C., Zhao, J., & Chu, C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03233a · Cited by 23
Akl, M. A., Kartal-Hodzic, A., Suutari, T., Oksanen, T., Montagner, I. M., Rosato, A., Ismael, H. R., Afouna, M. I., Caliceti, P., Yliperttula, M. L., et al. (2019) · ACS Omega · doi:10.1021/acsomega.9b02086 · Cited by 23
Influences of surface coating of PLGA nanoparticles on immune activation of macrophages
Chen, X., & Gao, C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03080k · Cited by 22
PEGylated quaternized copolymer/DNA complexes for gene delivery
Vroman, B., Ferreira, I., Jérôme, C., Jérôme, R., & Véronique Préat, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.044 · Cited by 22
Self-citationStudy of the Selective Uptake Progress of Aptamer‐ M odified PLGA Particles by Liver Cells
Yu, D.-H., Zhang, Y., Mao, Z., & Gao, C. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300165 · Cited by 21
F-127-PEI co-delivering docetaxel and TFPI-2 plasmid for nasopharyngeal cancer therapy
Liu, T., Zhang, X., Ke, B., Wang, Y., Wu, X., Jiang, G., Wu, T., & Nie, G. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.049 · Cited by 21
Li, N., Zhao, Z., Ma, H., Liu, Y., Nwafor, E.-O., Zhu, S., Jia, L., Pang, X., Han, Z., Tian, B., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00341 · Cited by 21
Nanomaterials for Enhanced Immunity as an Innovative Paradigm in Nanomedicine
Seth, A., Oh, D., & Lim, Y. T. (2015) · Nanomedicine · doi:10.2217/nnm.14.200 · Cited by 21
M cell specific markers in man and domestic animals: Valuable tools in vaccine development
Casteleyn, C. R., Broeck, W. V. D., Gebert, A., Tambuyzer, B. R., Cruchten, S. J. M. V., & Ginneken, C. J. V. (2013) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2013.03.002 · Cited by 20
Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines
Lambricht, L., Vanvarenberg, K., Beuckelaer, A. D., Hoecke, L. V., Grooten, J., Učakar, B., Lipnik, P., Sanders, N. N., Lienenklaus, S., Véronique Préat, A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.122 · Cited by 21
Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
Reddiar, S. B., Xie, Y., Abdallah, M., Han, S., Hu, L., Feeney, O. M., Gracia, G., Anshabo, A., Lu, Z., Farooq, M. A., et al. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001159 · Cited by 20
Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
Masloh, S., Culot, M., Gosselet, F., Chevrel, A., Scapozza, L., & Labouebe, M. Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051415 · Cited by 20
Targeted Delivery Using Biodegradable Polymeric Nanoparticles
Fattal, E., Hillaireau, H., Mura, S., Nicolas, J., & Tsapis, N. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0881-9_10 · Cited by 21
Hussain, N. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.053 · Cited by 19
Metadata
- Authors
- Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Schneider, Y.-J., & Préat, V.
- Affiliations
- UCLouvain (BE)
- University of Liège (BE)
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 120
- Issue
- 3
- Pages
- 195-204
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1982938211
- Cited by
- 331
- References
- 37
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 9 · 2023: 12 · 2022: 17 · 2021: 15 · 2020: 23 · 2019: 19 · 2018: 26 · 2017: 20 · 2016: 24 · 2015: 22 · 2014: 21 · 2013: 21 · 2012: 23
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- oral immunization, M cells, RGD peptide, photografting, follicle-associated epithelium, nanoparticle uptake, ovalbumin, IgG antibody response, oral vaccine delivery
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Administration, Oral, Animals, Epithelial Cells, Female, Ovarian Follicle, Humans, Immunization, Secondary, Injections, Intramuscular, Intestinal Mucosa, Mice, Inbred Strains, Oligopeptides, Ovalbumin, Peyer's Patches, Polyethylene Glycols, Polyglycolic Acid, Polymers, Vaccination, Fluorescein-5-isothiocyanate, Coculture Techniques, Caco-2 Cells, Integrin beta1, Lactic Acid, Integrin alpha5beta1, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
